companydata.dkcompanydata.dk

MS-OMICS ApS: Financial statements 2019

CVR: 36070374

Source: annual report 2019, Danish Business Authority

01/01/201931/12/2019

MS-OMICS ApS (CVR 36070374) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,645,692 and a net result of DKK -45,231 compared with DKK -945,431 the year before. That is an increase of 103.7% compared with the year before. Equity in the 2019 report amounted to DKK 417,947. The solvency ratio was 6.5%. The company had 5 employees in the financial year.

Gross Profit
DKK 2,645,692
Profit/Loss
DKK -45,231
Equity
DKK 417,947
Total Assets
DKK 6,397,590
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-2.6 mio.-45 t.418 t.5
2018-1.3 mio.-945 t.463 t.5
2017-1 mio.146 t.-591 t.3
2016-686 t.129 t.-738 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

MS-OMICS ApS: The 2018 annual report is outMar 22, 2019

MS-OMICS ApS has published its annual report for 2018. Gross profit came to DKK 1,299,069, and the net result was DKK -945,431.

Torben Thomasen joins the board of MS-OMICS ApSFeb 28, 2019

As of February 28, 2019, Torben Thomasen has joined the board of directors of MS-OMICS ApS.

About MS-OMICS ApS

MS-OMICS ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Anders Mohr Christensen. The company is owned by Clinical-Microbiomics A/S. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 16,799,037 and a net result of DKK 806,990 compared with DKK 2,341,741 the year before. Equity in the 2025 report amounted to DKK 3,170,348.

Source: annual report 2025, Danish Business Authority